Document is current
Any future updates will be listed below
-
Authors
Hoffmann, Verena S. https://orcid.org/0000-0003-1478-5390
Schönecker, Sonja https://orcid.org/0000-0003-4499-7861
Amin, Moustafa
Reidler, Paul https://orcid.org/0000-0001-7961-3018
Brauer, Anna
Kopczak, Anna https://orcid.org/0000-0002-5037-2342
Wunderlich, Silke https://orcid.org/0000-0003-1208-3686
Poli, Sven https://orcid.org/0000-0002-0286-8781
Althaus, Katharina https://orcid.org/0000-0002-9004-4335
Müller, Susanne https://orcid.org/0009-0007-6099-4333
Mansmann, Ulrich https://orcid.org/0000-0002-9955-8906
Kellert, Lars https://orcid.org/0000-0002-4967-8336
-
Clinical Trials BETA
Clinical trials referenced in this document:
drks00024407 at German Clinical Trials RegisterDocuments that mention this clinical trial
A novel prediction score determining individual clinical outcome 3 months after juvenile stroke (PREDICT-score)
https://doi.org/10.1007/s00415-024-12552-5
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie (01ZZ1804B, 01ZZ1804C)
Klinikum der Universität München
- License Information
-
More Information
Article History
Received: 16 May 2024
Revised: 24 June 2024
Accepted: 27 June 2024
First Online: 31 July 2024
Declarations
:
: VH, SS, MA, PR, AB, AK, SW UM, SV, KA, SM and UM report no conflicts of interest. LK has received funding for travel or speaker honoraria from Alexion, AstraZeneca, Bayer Vital, Boehringer Ingelheim, Bristol-Meyer-Squibb, Daiichi Sankyo, and Pfizer outside of this study.
: Ethical approval for retrospective analysis of data has been obtained at the local ethics committee at LMU Munich (21-0136). The study is conducted according to the Declaration of Helsinki.
